Lawrence Rasouliyan

2.2k total citations
47 papers, 1.5k citations indexed

About

Lawrence Rasouliyan is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Lawrence Rasouliyan has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 12 papers in Rheumatology and 12 papers in Immunology. Recurrent topics in Lawrence Rasouliyan's work include Cystic Fibrosis Research Advances (12 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Spondyloarthritis Studies and Treatments (9 papers). Lawrence Rasouliyan is often cited by papers focused on Cystic Fibrosis Research Advances (12 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Spondyloarthritis Studies and Treatments (9 papers). Lawrence Rasouliyan collaborates with scholars based in United States, United Kingdom and Switzerland. Lawrence Rasouliyan's co-authors include David J. Pasta, Jeffrey S. Wagener, Bradley E. Chipps, Michael W. Konstan, Tmirah Haselkorn, Wayne J. Morgan, Ashley Yegin, Alexandra L. Quittner, Gregory S. Sawicki and Donald R. VanDevanter and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and CHEST Journal.

In The Last Decade

Lawrence Rasouliyan

42 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Rasouliyan United States	19	1.1k	488	154	122	111	47	1.5k
Mary K. Miller United States	16	484 0.5×	596 1.2×	91 0.6×	112 0.9×	89 0.8×	34	1.0k
Charles S. Dayton United States	18	851 0.8×	399 0.8×	100 0.6×	37 0.3×	55 0.5×	24	1.1k
Cynthia B. Whitman United States	15	202 0.2×	68 0.1×	145 0.9×	55 0.5×	67 0.6×	21	917
Kuruswamy Thurai Prasad India	21	911 0.8×	463 0.9×	338 2.2×	35 0.3×	16 0.1×	141	1.5k
Anthony D. Sung United States	19	178 0.2×	118 0.2×	122 0.8×	110 0.9×	74 0.7×	93	1.1k
Neil Johnston Canada	12	450 0.4×	550 1.1×	221 1.4×	102 0.8×	22 0.2×	26	944
Roeland A. Veenendaal Netherlands	20	159 0.1×	62 0.1×	266 1.7×	122 1.0×	70 0.6×	49	1.3k
Enrico Compalati Italy	26	464 0.4×	1.7k 3.5×	53 0.3×	119 1.0×	340 3.1×	81	2.6k
Gaia Pellegatta Italy	18	422 0.4×	58 0.1×	66 0.4×	30 0.2×	44 0.4×	66	1.2k
Wim Hameeteman Netherlands	16	207 0.2×	170 0.3×	316 2.1×	46 0.4×	21 0.2×	40	1.3k

Countries citing papers authored by Lawrence Rasouliyan

Since Specialization

Citations

This map shows the geographic impact of Lawrence Rasouliyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Rasouliyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Rasouliyan more than expected).

Fields of papers citing papers by Lawrence Rasouliyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Rasouliyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Rasouliyan. The network helps show where Lawrence Rasouliyan may publish in the future.

Co-authorship network of co-authors of Lawrence Rasouliyan

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Rasouliyan. A scholar is included among the top collaborators of Lawrence Rasouliyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Rasouliyan. Lawrence Rasouliyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rasouliyan, Lawrence, Lawrence Rasouliyan, Timothy Fitzgerald, et al.. (2024). 54043 Guselkumab for Treatment of Plaque Psoriasis: Persistence and Switching in Real-World Clinical Practices in the US. Journal of the American Academy of Dermatology. 91(3). AB223–AB223.

Wang, Yan, Lawrence Rasouliyan, & Vikas Kumar. (2024). RWD98 Reasons for Biologic Treatment Alteration in Inflammatory Bowel Disease: Insights from Unstructured Clinical Notes Derived from Large Language Models. Value in Health. 27(12). S592–S592. 1 indexed citations

Black, David F., et al.. (2024). HPR113 Social Determinants of Health and Use of Glucagon-like Peptide-1 Receptor Agonists in the Pediatric Population. Value in Health. 27(12). S297–S297. 1 indexed citations

Rasouliyan, Lawrence, et al.. (2021). PIT1 Negative Pressure Wound Therapy for Pressure Ulcer: Effect on Outcomes and Utilization Using Real-World DATA. Value in Health. 24. S122–S122. 1 indexed citations

Coates, Laura C., Johan K. Wallman, Dennis McGonagle, et al.. (2019). Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies. Arthritis Research & Therapy. 21(1). 266–266. 13 indexed citations

Coates, Laura C., Dafna D. Gladman, Peter Nash, et al.. (2018). Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study. Arthritis Research & Therapy. 20(1). 272–272. 27 indexed citations

Coates, Laura C., Tore K Kvien, Peter Nash, et al.. (2017). AB0772 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved low disease activity related to psoriatic arthritis disease activity score (PASDAS). Annals of the Rheumatic Diseases. 76. 1326–1326. 2 indexed citations

Coates, Laura C., Peter Nash, Tore K Kvien, et al.. (2017). Secukinumab Provides Sustained Minimal Disease Activity (MDA) and Remission Related to Disease Activity Index for Psoriatic Arthritis (DAPSA): 2-Year Results from a Phase 3 Study. Queensland's institutional digital repository (The University of Queensland). 69. 21–22. 1 indexed citations

McInnes, Iain B., T.K. Kvien, Luminita Pricop, et al.. (2017). AB0766 Secukinumab provides sustained remission and low disease activity related to disease activity index for psoriatic arthritis (DAPSA): 2 year results from the future 2 study. Annals of the Rheumatic Diseases. 76. 1323–1324. 1 indexed citations

10.

Stalmans, Peter, et al.. (2015). Interim Results From INJECT: INvestigation of JETREA in Patients With Confirmed Vitreomacular Traction. Investigative Ophthalmology & Visual Science. 56(7). 1237–1237. 2 indexed citations

11.

Luskin, Allan T., Bradley E. Chipps, Lawrence Rasouliyan, et al.. (2014). Impact of Asthma Exacerbations and Asthma Triggers on Asthma-related Quality of Life in Patients with Severe or Difficult-to-Treat Asthma. The Journal of Allergy and Clinical Immunology In Practice. 2(5). 544–552.e2. 78 indexed citations

12.

Goldberg, Stuart L., Jörge E. Cortes, Carlo Gambacorti‐Passerini, et al.. (2014). Predictors of performing response monitoring in patients with chronic-phase chronic myeloid leukemia (CP-CML) in a prospective observational study (SIMPLICITY).. Journal of Clinical Oncology. 32(30_suppl). 116–116. 4 indexed citations

13.

Zeiger, Robert S., Ashley Yegin, F. Estelle R. Simons, et al.. (2012). Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Annals of Allergy Asthma & Immunology. 108(2). 81–87.e3. 40 indexed citations

14.

Ren, Clement L., Michael W. Konstan, Ashley Yegin, et al.. (2012). Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis. Journal of Cystic Fibrosis. 11(4). 293–299. 45 indexed citations

15.

Sawicki, Gregory S., Lawrence Rasouliyan, Ann McMullen, et al.. (2010). Longitudinal assessment of health‐related quality of life in an observational cohort of patients with cystic fibrosis. Pediatric Pulmonology. 46(1). 36–44. 81 indexed citations

16.

Quittner, Alexandra L., Michael S. Schechter, Lawrence Rasouliyan, et al.. (2009). Impact of Socioeconomic Status, Race, and Ethnicity on Quality of Life in Patients With Cystic Fibrosis in the United States. CHEST Journal. 137(3). 642–650. 97 indexed citations

17.

Campbell, Jonathan D., Larry Borish, Tmirah Haselkorn, et al.. (2008). The response to combination therapy treatment regimens in severe/difficult-to-treat asthma. European Respiratory Journal. 32(5). 1237–1242. 13 indexed citations

18.

VanDevanter, Donald R., Lawrence Rasouliyan, Thomas M. Murphy, et al.. (2008). Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatric Pulmonology. 43(8). 739–744. 18 indexed citations

19.

Zinner, Norman R., Les Noe, Lawrence Rasouliyan, Thomas Märshall, & Raafat Seifeldin. (2008). Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Current Medical Research and Opinion. 24(6). 1583–1591. 22 indexed citations

20.

Seifeldin, Raafat, et al.. (2006). MP-04.06. Urology. 68. 70–71. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact